Hung‐Yuan Cheng
About
Hung‐Yuan Cheng is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology.
According to data from OpenAlex, Hung‐Yuan Cheng has authored 64 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Hung‐Yuan Cheng's work include Electrochemical Analysis and Applications (8 papers), High Altitude and Hypoxia (6 papers) and Electrochemical sensors and biosensors (4 papers). Hung‐Yuan Cheng is often cited by papers focused on Electrochemical Analysis and Applications (8 papers), High Altitude and Hypoxia (6 papers) and Electrochemical sensors and biosensors (4 papers). Hung‐Yuan Cheng collaborates with scholars based in United Kingdom, United States and Australia. Hung‐Yuan Cheng's co-authors include Stephen R. Johnson, Keith W. Ward, Daniel F. Veber, Kenneth D. Kopple, Brian R. Smith, Giora Feuerstein, Tianli Yue, Ralph N. Adams, Andrew Dagens and Louise Sigfrid and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Analytical Chemistry.
In The Last Decade
Hung‐Yuan Cheng
60 papers receiving 8.0k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hung‐Yuan Cheng United Kingdom | 26 | 3.1k | 2.6k | 2.2k | 791 | 746 | 64 | 8.3k | ||
| Brian R. Smith United States | 38 | 4.3k 1.4× | 2.6k 1.0× | 2.2k 1.0× | 994 1.3× | 1.5k 2.0× | 125 | 10.5k | ||
| Paul D. Leeson United Kingdom | 42 | 5.4k 1.7× | 3.0k 1.1× | 2.8k 1.3× | 879 1.1× | 728 1.0× | 111 | 10.6k | ||
| Stefano Alcaro Italy | 52 | 3.7k 1.2× | 3.3k 1.2× | 993 0.4× | 1.9k 2.4× | 491 0.7× | 300 | 8.4k | ||
| Jason K. Perry United States | 28 | 5.5k 1.8× | 1.9k 0.7× | 3.1k 1.4× | 993 1.3× | 925 1.2× | 60 | 10.3k | ||
| Stefano Moro Italy | 56 | 7.4k 2.4× | 3.6k 1.4× | 1.8k 0.8× | 745 0.9× | 1.2k 1.6× | 354 | 12.7k | ||
| Asimul Islam India | 46 | 4.4k 1.4× | 741 0.3× | 1.2k 0.5× | 730 0.9× | 676 0.9× | 316 | 7.7k | ||
| Stefan Laufer Germany | 62 | 6.8k 2.2× | 4.0k 1.5× | 1.2k 0.5× | 2.2k 2.8× | 1.8k 2.3× | 469 | 15.2k | ||
| Guixia Liu China | 39 | 3.4k 1.1× | 1.4k 0.5× | 4.0k 1.8× | 842 1.1× | 502 0.7× | 199 | 7.8k | ||
| Giulio Vistoli Italy | 39 | 4.0k 1.3× | 1.7k 0.7× | 967 0.4× | 626 0.8× | 693 0.9× | 217 | 8.2k | ||
| Andrew D. Mesecar United States | 60 | 6.1k 2.0× | 1.5k 0.6× | 2.0k 0.9× | 575 0.7× | 592 0.8× | 167 | 11.6k |
Countries citing papers authored by Hung‐Yuan Cheng
Since
Specialization
Citations
This map shows the geographic impact of Hung‐Yuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Yuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Yuan Cheng more than expected).
Fields of papers citing papers by Hung‐Yuan Cheng
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hung‐Yuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Yuan Cheng. The network helps show where Hung‐Yuan Cheng may publish in the future.
Co-authorship network of co-authors of Hung‐Yuan Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Hung‐Yuan Cheng. A scholar is included among the top collaborators of Hung‐Yuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung‐Yuan Cheng. Hung‐Yuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chen, Jiali, et al.. (2025). Facilitators and barriers affecting the implementation of diabetes prevention programs in primary care settings: A qualitative meta-synthesis from a multi-stakeholder perspective. International Journal of Nursing Studies. 170. 105156–105156.
2.
Harriss, Eli, Hung‐Yuan Cheng, Katrin Probyn, et al.. (2025). Living Rapid Research Needs Appraisal (RRNA) for Priority Diseases Protocol. 10. 668–668.
3.
Cheng, Hung‐Yuan, Andrew D Beswick, Wendy Bertram, et al.. (2025). What proportion of people have long-term pain after total hip or knee replacement? An update of a systematic review and meta-analysis. BMJ Open. 15(5). e088975–e088975.
4.
Thomas, Kyla H, Michael N Dalili, Hung‐Yuan Cheng, et al.. (2024). Prevalence of problematic pharmaceutical opioid use in patients with chronic non‐cancer pain: A systematic review and meta‐analysis. Addiction. 119(11). 1904–1922.
5.
Antoniou, George Α., Marc L. Schermerhorn, Thomas L. Forbes, et al.. (2022). Risk factors, risk stratification and risk-specific surveillance strategies after endovascular aneurysm repair: study protocol for a Delphi study by the International RIsk Stratification in EVAR (IRIS-EVAR) working group. BMJ Open. 12(4). e055803–e055803.
6.
Lipworth, Samuel, Ishmeala Rigby, Hung‐Yuan Cheng, et al.. (2021). From severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) to coronavirus disease 2019 (COVID-19): a systematic review of the quality and responsiveness of clinical management guidelines in outbreak settings. Oxford University Research Archive (ORA) (University of Oxford). 6. 170–170.
7.
Michelen, Melina, Lakshmi Manoharan, Natalie Elkheir, et al.. (2021). Characterising long COVID: a living systematic review. BMJ Global Health. 6(9). e005427–e005427.
8.
Thom, Howard, Hung‐Yuan Cheng, Edna Keeney, et al.. (2021). Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis. Dermatology and Therapy. 12(1). 185–194.
9.
Brandner, Sebastian, Alexandra McAleenan, Claire Kelly, et al.. (2021). MGMTpromoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro-Oncology. 23(9). 1457–1469.
10.
Salam, Alex P., Hung‐Yuan Cheng, Tansy Edwards, et al.. (2021). Time to reconsider the role of ribavirin in Lassa fever. PLoS neglected tropical diseases. 15(7). e0009522–e0009522.
11.
Eyles, Emily, Paul Moran, Chukwudi Okolie, et al.. (2021). Systematic review of the impact of the COVID-19 pandemic on suicidal behaviour amongst health and social care workers across the world. Journal of Affective Disorders Reports. 6. 100271–100271.
12.
Dagens, Andrew, Louise Sigfrid, Samuel Lipworth, et al.. (2020). Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ. 369. m1936–m1936.
13.
Cheng, Hung‐Yuan, Luke A. McGuinness, Roy G. Elbers, et al.. (2020). Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis. BMJ. 371. m3934–m3934.
14.
Thom, Howard, Jeroen P. Jansen, Jason Shafrin, et al.. (2020). Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis. BMJ Open. 10(9). e034147–e034147.
15.
Young, Amber, Barnaby C Reeves, Hung‐Yuan Cheng, et al.. (2019). Risk of bias and reporting completeness of randomised controlled trials in burn care: protocol for a systematic review. BMJ Open. 9(12). e033472–e033472.
16.
Cheng, Hung‐Yuan, Roy G. Elbers, Julian P. T. Higgins, et al.. (2017). Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol). Systematic Reviews. 6(1). 77–77.
17.
Petousi, Nayia, Quentin P. P. Croft, Gianpiero L. Cavalleri, et al.. (2013). Tibetans living at sea level have a hyporesponsive hypoxia-inducible factor system and blunted physiological responses to hypoxia. Journal of Applied Physiology. 116(7). 893–904.
18.
Veber, Daniel F., Stephen R. Johnson, Hung‐Yuan Cheng, et al.. (2002). Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. Journal of Medicinal Chemistry. 45(12). 2615–2623.
19.
Cheng, Hung‐Yuan, et al.. (1996). Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1284(1). 20–28.
20.
Yue, Tianli, et al.. (1994). Carvedilol, a new vasodilating adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils. Cardiovascular Research. 28(3). 400–406.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Brian R. Smith Breakdown of academic impact, for papers by Paul D. Leeson Breakdown of academic impact, for papers by Stefano Alcaro Breakdown of academic impact, for papers by Jason K. Perry Breakdown of academic impact, for papers by Stefano Moro Breakdown of academic impact, for papers by Asimul Islam Breakdown of academic impact, for papers by Stefan Laufer Breakdown of academic impact, for papers by Guixia Liu Breakdown of academic impact, for papers by Giulio Vistoli Breakdown of academic impact, for papers by Andrew D. Mesecar